πŸ‡ΊπŸ‡Έ FDA
Patent

US 11427581

JAK inhibitor and use thereof

granted A61KA61K31/437A61P

Quick answer

US patent 11427581 (JAK inhibitor and use thereof) held by ZHUHAI UNITED LABORATORIES CO., LTD. expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ZHUHAI UNITED LABORATORIES CO., LTD.
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/437, A61P, A61P19/02